StockData
Panacea Life Sciences Holdings, Inc. logo

Panacea Life Sciences Holdings, Inc. (PLSH) stock

PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Panacea Life Sciences free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Panacea Life Sciences's free cash flow for the twelve months ending Jun 30, 2023 was -$2.28M. For fiscal 2023 it was -$1.59M. The highest annual figure on record is -$405.67K in fiscal 2014.

Annual free cash flow

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$1.59M–
FY2022Dec 31, 2022-$2.64M–
FY2021Dec 31, 2021-$4.09M–
FY2020Dec 31, 2020-$10.85M–
FY2019Dec 31, 2019-$6.29M–
FY2018Dec 31, 2018-$465.76K–
FY2016Dec 31, 2016-$889.66K–
FY2015Dec 31, 2015-$640.02K–
FY2014Dec 31, 2014-$405.67K–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2024Mar 31, 2024-$362.09K–
Q2 FY2023Jun 30, 2023-$492.67K–
Q1 FY2023Mar 31, 2023-$329.07K–
Q4 FY2022Dec 31, 2022-$621.84K–
Q3 FY2022Sep 30, 2022-$838.44K–
Q2 FY2022Jun 30, 2022-$737.34K–
Q1 FY2022Mar 31, 2022-$445.77K–
Q4 FY2021Dec 31, 2021-$1.22M–
Q3 FY2021Sep 30, 2021-$738.70K–
Q2 FY2021Jun 30, 2021-$1.24M–
Q1 FY2021Mar 31, 2021-$882.00K–
Q4 FY2020Dec 31, 2020-$925.80K–
Q3 FY2020Sep 30, 2020-$3.90M–
Q2 FY2020Jun 30, 2020-$5.85M–
Q1 FY2020Mar 31, 2020-$164.28K–
Q4 FY2019Dec 31, 2019-$673.62K–
Q3 FY2019Sep 30, 2019-$1.74M–
Q2 FY2019Jun 30, 2019-$2.01M–
Q1 FY2019Mar 31, 2019-$1.86M–
Q4 FY2018Dec 31, 2018-$57.83K–
Q3 FY2018Sep 30, 2018-$73.92K–
Q2 FY2018Jun 30, 2018-$38.73K–
Q1 FY2018Mar 31, 2018-$295.28K–
Q4 FY2016Dec 31, 2016-$406.82K–
Q3 FY2016Sep 30, 2016-$129.28K–
Q2 FY2016Jun 30, 2016-$187.03K–
Q1 FY2016Mar 31, 2016-$166.54K–
Q4 FY2015Dec 31, 2015-$69.14K–
Q1 FY2015Mar 31, 2015-$82.68K–
Q4 FY2014Dec 31, 2014-$291.04K–
Q3 FY2014Sep 30, 2014-$15.13K–

More Panacea Life Sciences figures

See a number that looks wrong?